机构:[1]Department of Geriatric Medicine, No. 4 West China Teaching Hospital, Sichuan University, Chengdu, People’s Republic of China[2]State Key Laboratory of Biotherapy/ Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, People’s Republic of China四川大学华西医院[3]Department of Cell Biology, Institute of Immunology, Medical College of Henan University, Kaifeng, People’s Republic of China[4]Department of Immunology, Key Laboratory of Cellular and Molecular Immunology, Henan University, Kaifeng, People’s Republic of China
the National High-Tech Research and Development
Program of China (863 Plan) (no. 2014AA020706).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类|3 区医学
小类|4 区免疫学4 区传染病学4 区微生物学
最新[2023]版:
无
第一作者:
第一作者机构:[1]Department of Geriatric Medicine, No. 4 West China Teaching Hospital, Sichuan University, Chengdu, People’s Republic of China[2]State Key Laboratory of Biotherapy/ Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, People’s Republic of China
通讯作者:
推荐引用方式(GB/T 7714):
Wan Yang,Li Meng,Zhang Hailong,et al.Development of a Recombinant Xenogeneic Tumor Necrosis Factor Alpha Protein Vaccine To Protect Mice from Experimental Colitis.[J].Clinical and vaccine immunology : CVI.2015,22(12):1269-75.doi:10.1128/CVI.00331-15.
APA:
Wan Yang,Li Meng,Zhang Hailong,Zheng Xiuran,Yu Chaoheng...&Wei Yuquan.(2015).Development of a Recombinant Xenogeneic Tumor Necrosis Factor Alpha Protein Vaccine To Protect Mice from Experimental Colitis..Clinical and vaccine immunology : CVI,22,(12)
MLA:
Wan Yang,et al."Development of a Recombinant Xenogeneic Tumor Necrosis Factor Alpha Protein Vaccine To Protect Mice from Experimental Colitis.".Clinical and vaccine immunology : CVI 22..12(2015):1269-75